ING Groep NV Buys 35,807 Shares of HCA Healthcare, Inc. (NYSE:HCA)

ING Groep NV increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 267.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 49,201 shares of the company's stock after buying an additional 35,807 shares during the period. ING Groep NV's holdings in HCA Healthcare were worth $19,997,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Bangor Savings Bank raised its stake in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company's stock worth $27,000 after buying an additional 45 shares during the period. MFA Wealth Advisors LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth approximately $27,000. Unique Wealth Strategies LLC bought a new stake in shares of HCA Healthcare during the second quarter worth $28,000. GPS Wealth Strategies Group LLC boosted its stake in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company's stock worth $31,000 after purchasing an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. bought a new stake in shares of HCA Healthcare in the second quarter valued at about $33,000. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company's stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock worth $5,608,990 over the last quarter. Corporate insiders own 1.60% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA traded down $2.55 during midday trading on Friday, hitting $342.96. The company's stock had a trading volume of 1,859,026 shares, compared to its average volume of 1,186,336. The company's fifty day simple moving average is $386.00 and its two-hundred day simple moving average is $357.03. The stock has a market capitalization of $86.87 billion, a price-to-earnings ratio of 15.40, a price-to-earnings-growth ratio of 1.34 and a beta of 1.68. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a one year low of $238.82 and a one year high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.77%. The ex-dividend date is Friday, December 13th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.85%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Morgan Stanley began coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an "equal weight" rating and a $427.00 target price on the stock. KeyCorp decreased their price objective on HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating for the company in a report on Monday, October 28th. Royal Bank of Canada boosted their price target on HCA Healthcare from $378.00 to $405.00 and gave the stock an "outperform" rating in a research report on Friday, August 23rd. UBS Group raised their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a "buy" rating in a research note on Wednesday, August 14th. Finally, Wolfe Research raised shares of HCA Healthcare to a "strong-buy" rating in a research report on Thursday, August 29th. Five analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and an average target price of $385.00.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.